Servier is a global independent pharmaceutical group governed by a Foundation. With a strong international presence in 150 countries and a total revenue of 4.7 B€ in 2021, Servier employs 21,800 people worldwide. To accelerate therapeutic innovation for the benefit of patients, the Group is committed to open and collaborative innovation with academic partners, pharmaceutical groups, and biotech companies. Servier growth is based on a sustained commitment to cardiovascular and metabolic diseases, oncology, neurosciences and immuno-inflammatory diseases. More information: servier.com
December 12th & 13th, 2023
IN-PERSON | MARSEILLE, FR
December 15th, 2023
ONLINE MEETINGS